BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

TRANSGENE S.A. 

11 rue de MOLSHEIM, 67082
Strasbourg
Cedex      France
Phone: 011-33-3-88-27-91-21 Fax: 011-33-3-88-27-91-11


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Gene Therapy

Collaborations

Human Genome Sciences, Inc.  Gene Therapy Partnerships





 Company News
TRANSGENE (ENX:TNG) Presents New Data With TG1050, An Immunotherapy Being Developed To Treat Chronic Hepatitis B, At The International Liver Congress 2015 4/23/2015 11:25:17 AM
TRANSGENE (ENX:TNG) Reports First Quarter 2015 Financial Results 4/22/2015 11:25:39 AM
TRANSGENE (ENX:TNG) Presents New Pre-Clinical Data At AACR On (I) The Combination Of TG4010 With Immune Checkpoint Inhibitors; (Ii) TG3003, An Anti-CD115 Monoclonal Antibody 4/21/2015 11:47:14 AM
TRANSGENE (ENX:TNG): Agreement With FDA Announced For Special Protocol Assessment For Upcoming Phase 3 Pexa-Vec Trial In Advanced Liver Cancer 4/16/2015 10:14:10 AM
TRANSGENE (ENX:TNG) Reports 2014 Financial Results And Outlines Promising Clinical Pipeline 3/25/2015 9:53:06 AM
TRANSGENE (ENX:TNG) Announces New Pre-Clinical Data With TG4010 In Combination With Immune Checkpoint Inhibitors And TG3003 (Humanized Mab Anti-CD115) To Be Presented At American Association for Cancer Research 3/19/2015 12:52:59 PM
TRANSGENE (ENX:TNG) Announces Financial Calendar For 2015 1/8/2015 10:51:20 AM
TRANSGENE (ENX:TNG) Announces Events Calendar For Fourth Quarter 2014 10/29/2014 8:56:35 AM
TRANSGENE (ENX:TNG) Announces Third Quarter 2014 Financial Results 10/22/2014 9:36:46 AM
TRANSGENE (ENX:TNG) Announces Management Changes 10/9/2014 10:58:35 AM
12345678910...